Psoriasis exacerbation after a flu-like syndrome during anti-TNF-alpha therapy.
Cassano
Nicoletta
N
Coviello
Carmela
C
Loconsole
Francesco
F
Miracapillo
Antonio
A
Vena
Gino Antonio
GA
D000328:Adult; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011565:Psoriasis / Q000188:drug therapy / Q000503:physiopathology*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept